Literature DB >> 7096999

Neutralizing antibodies against 33 human adenoviruses in normal children in Rome.

E D'Ambrosio, N Del Grosso, A Chicca, M Midulla.   

Abstract

There are few data about the distribution of neutralizing antibodies (NA) against adenovirus types in the Italian population, especially the high-numbered ones. We tested the sera from 453 children and 51 young adults to evaluate NA against adenovirus prototypes 1-33. Using the microneutralization test, 338 (74.6%) of the children's sera were positive for at least one adenovirus type. Antibody to type 2 was the most frequently detected followed, in descending order, by antibody to types 5, 1 and 3. All these types are known to be associated with disease but antibody to type 7, a type also associated with disease, was less frequent than that to other serotypes such as 18 and 31, the pathogenicity of which in man is not clearly established. The antibody positivity rate rose with age for the more frequent types while it did not vary for the less frequent ones. The number of sera with NA against more than one adenovirus type increased with age. With regard to types 1-8, we found that their frequencies in Italy were similar to those found in the U.S.A.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7096999      PMCID: PMC2134173          DOI: 10.1017/s0022172400070650

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  8 in total

1.  Adenovirus neutralizing antibodies in persons on Taiwan.

Authors:  F H TAI; J T GRAYSTON
Journal:  Proc Soc Exp Biol Med       Date:  1962-04

2.  The distribution of adenovirus antibodies in normal children.

Authors:  C W POTTER; W I SHEDDEN
Journal:  J Hyg (Lond)       Date:  1963-03

3.  Adenovirus infection in childhood. An epidemiological and clinical survey among Swedish children.

Authors:  G STERNER
Journal:  Acta Paediatr Suppl       Date:  1962

4.  Acute respiratory diseases of viral etiology. II. Adenoviruses.

Authors:  J A BELL; W P ROWE; L ROSEN
Journal:  Am J Public Health Nations Health       Date:  1962-06

5.  The virus watch program: a continuing surveillance of viral infections in metropolitan New York families. VI. Observations of adenovirus infections: virus excretion patterns, antibody response, efficiency of surveillance, patterns of infections, and relation to illness.

Authors:  J P Fox; C D Brandt; F E Wassermann; C E Hall; I Spigland; A Kogon; L R Elveback
Journal:  Am J Epidemiol       Date:  1969-01       Impact factor: 4.897

6.  Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections.

Authors:  N J Schmidt; E H Lennette; C J King
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

7.  New human adenovirus (candidate adenovirus 36), a novel member of subgroup D.

Authors:  R Wigand; H Gelderblom; G Wadell
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

8.  Infections in 18,000 infants and children in a controlled study of respiratory tract disease. I. Adenovirus pathogenicity in relation to serologic type and illness syndrome.

Authors:  C D Brandt; H W Kim; A J Vargosko; B C Jeffries; J O Arrobio; B Rindge; R H Parrott; R M Chanock
Journal:  Am J Epidemiol       Date:  1969-12       Impact factor: 4.897

  8 in total
  36 in total

1.  Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors.

Authors:  Mieke C Sprangers; Wandena Lakhai; Wouter Koudstaal; Marielle Verhoeven; Björn F Koel; Ronald Vogels; Jaap Goudsmit; Menzo J E Havenga; Stefan Kostense
Journal:  J Clin Microbiol       Date:  2003-11       Impact factor: 5.948

2.  Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer.

Authors:  E J Kremer; S Boutin; M Chillon; O Danos
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Evidence for the role of a human intestinal adenovirus in the pathogenesis of coeliac disease.

Authors:  M F Kagnoff; Y J Paterson; P J Kumar; D D Kasarda; F R Carbone; D J Unsworth; R K Austin
Journal:  Gut       Date:  1987-08       Impact factor: 23.059

4.  PCR analysis of egyptian respiratory adenovirus isolates, including identification of species, serotypes, and coinfections.

Authors:  David Metzgar; Miguel Osuna; Samuel Yingst; Magda Rakha; Kenneth Earhart; Diaa Elyan; Hala Esmat; Magdi D Saad; Adriana Kajon; Jianguo Wu; Gregory C Gray; Margaret A K Ryan; Kevin L Russell
Journal:  J Clin Microbiol       Date:  2005-11       Impact factor: 5.948

5.  A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques.

Authors:  Stefania Capone; Annalisa Meola; Bruno Bruni Ercole; Alessandra Vitelli; Monica Pezzanera; Lionello Ruggeri; Mary Ellen Davies; Rosalba Tafi; Claudia Santini; Alessandra Luzzago; Tong-Ming Fu; Andrew Bett; Stefano Colloca; Riccardo Cortese; Alfredo Nicosia; Antonella Folgori
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

6.  Three-dimensional structure of canine adenovirus serotype 2 capsid.

Authors:  Guy Schoehn; Majida El Bakkouri; Céline M S Fabry; Oliver Billet; Leandro F Estrozi; Long Le; David T Curiel; Andrey V Kajava; Rob W H Ruigrok; Eric J Kremer
Journal:  J Virol       Date:  2008-01-23       Impact factor: 5.103

Review 7.  Genetic medicine strategies to protect against bioterrorism.

Authors:  Julie L Boyer; Ronald G Crystal
Journal:  Trans Am Clin Climatol Assoc       Date:  2006

8.  Canine adenovirus vectors for lung-directed gene transfer: efficacy, immune response, and duration of transgene expression using helper-dependent vectors.

Authors:  Anne Keriel; Céline René; Chad Galer; Joseph Zabner; Eric J Kremer
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

9.  Safety and immunogenicity of the Merck adenovirus serotype 5 (MRKAd5) and MRKAd6 human immunodeficiency virus type 1 trigene vaccines alone and in combination in healthy adults.

Authors:  Clayton Harro; Xiao Sun; Jon E Stek; Randi Y Leavitt; Devan V Mehrotra; Fubao Wang; Andrew J Bett; Danilo R Casimiro; John W Shiver; Mark J DiNubile; Erin Quirk
Journal:  Clin Vaccine Immunol       Date:  2009-07-15

10.  Repeated adenoviral administration into the biliary tract can induce repeated expression of the original gene construct in rat livers without immunosuppressive strategies.

Authors:  K Tominaga; S Kuriyama; H Yoshiji; A Deguchi; Y Kita; F Funakoshi; T Masaki; K Kurokohchi; N Uchida; T Tsujimoto; H Fukui
Journal:  Gut       Date:  2004-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.